Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Edwards Lifesciences, TAVR
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.
Edwards Lifesciences Corp (EW) Posted 70.82% Profit Margin Last Year—Can It Hold Up?
Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $71.13 which represents a decrease of $-1.43 or -1.97% from the prior close of $72.56. The stock opened at $72.5 and touched a low of $71.
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for transcatheter aortic valve replacement (TAVR).
11 Analysts Have This To Say About Edwards Lifesciences
In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
2d
on MSN
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Shares of Edwards Lifesciences Corp. advanced 4.86% to $72.56 Tuesday, on what proved to be an all-around great trading ...
1d
Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
Orange County Business Journal
3d
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...
Hosted on MSN
13h
Stifel Upgrades Edwards Lifesciences (EW)
Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.
Forbes
2d
Edwards Lifesciences
Edwards Lifesciences
Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
1d
Geneos Wealth Management Inc. Decreases Stake in Edwards Lifesciences Co. (NYSE:EW)
Geneos Wealth Management Inc. decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% ...
14d
Edwards Lifesciences downgraded to Underperform at Wolfe Research
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...
14d
Should Edwards Lifesciences Stock Stay in Your Portfolio Now?
EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.
2d
Brighton Jones LLC Buys New Shares in Edwards Lifesciences Co. (NYSE:EW)
Brighton Jones LLC purchased a new position in Edwards Lifesciences Co. (NYSE:EW – Free Report) in the fourth quarter, ...
6d
Smart Money Is Betting Big In Edwards Lifesciences Options
Today, Benzinga's options scanner spotted 8 options trades for Edwards Lifesciences. This is not a typical pattern. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
New York Stock Exchange
TAVR
Stifel
Wolfe Research
Feedback